• Rule Out Bowel Perforation Early in Scleroderma Patients with Abdominal Symptoms, Study Advises
  • FDA Paves Way for Phase 2 Testing of EHP-101 for Scleroderma
  • Combined Imaging Approach Can Help Diagnose Scleroderma Earlier, Study Indicates
  • Autoantibodies Linked to Genetic and Environmental Factors in Scleroderma, Study Finds
  • Small Molecule Holds Promise Against Fibrosis in Scleroderma, Other Disorders, Study Suggests
  • IVIG Therapy Can Help Reduce Corticosteroid Dosage for Scleroderma-associated Myopathy, Study Finds
  • Servier and UCL Partner to Battle Scleroderma and Lupus
  • Global Genes Awards Nearly $200K to Scleroderma Foundation, Other Rare Disease Organizations
  • Cedars-Sinai Receives $20M Donation to Create Kao Autoimmunity Institute and Scleroderma Program
  • Similar Symptoms Found in Scleroderma Patients in the U.S., Regardless of Their Immunosuppressant Use, Study Finds
  • Cantargia Starts Development of CAN10 Antibody for Scleroderma, Myocarditis
  • Galapagos Completes Enrollment in Phase 2a Trial Testing GLPG1690 in Diffuse Cutaneous Scleroderma